Jubilant Pharmova Ltd (BOM:530019)
₹ 1206.6 33.4 (2.85%) Market Cap: 191.07 Bil Enterprise Value: 218.08 Bil PE Ratio: 34.83 PB Ratio: 3.53 GF Score: 78/100

Q1 2021 Jubilant Life Sciences Ltd Earnings Call Transcript

Sep 04, 2020 / 11:30AM GMT
Release Date Price: ₹620.74 (+1.33%)
Operator

Good day and welcome to Jubilant Life Sciences Limited earnings conference call for the quarter ended June 30, 2020. (Operator instructions)

Please note that this conference is being recorded. I now hand the conference over to Mr. Hemant Bakhru, Head, Investor Relations. Thank you and over to you, sir.

Hemant Bakhru
Jubilant Life Sciences Ltd. - Head, IR

Thank you. Good evening, everybody. I'm Hemant Bakhru, Head, Investor Relations at Jubilant Life Sciences. Thank you for being with us on our Q1 FY21 earnings conference call. I would like to remind you that some of the statements made on the call today could be forward-looking in nature and a detailed disclaimer in this regard has been included in the press release that has been shared on our website.

On the call today we have Mr. Shyam Bhartia, Chairman; Mr. Hari Bhartia, Co-Chairman and Managing Director; Mr. Pramod Yadav, CEO, Jubilant Pharma; Mr. Rajesh Srivastava, CEO, Life Science Ingredients; and Mr. Alok Vaish, President and CEO, Jubilant Life Sciences Limited. I now invite Mr.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot